Home »
FDA Approves TicoVac (tick-borne encephalitis vaccine) to Prevent Tick-Borne Encephalitis (TBE) NEW YORK–(BUSINESS WIRE) August 13, 2021 — Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TicoVac (tick-borne
Dr. Siegel on heart risk from COVID vaccine in teens Fox News Medical contributor Dr. Marc Siegel discusses the risks of COVID vaccination among teens on ‘America Reports.’ The Food and Drug Administration says it
The Food and Drug Administration (FDA) is expected to announce a new warning for Johnson & Johnson’s COVID-19 vaccine, following preliminary reports of a rare nerve condition that developed in a very small fraction of
(Reuters) -Biogen Inc on Thursday said the U.S. Food and Drug Administration has narrowed use of its Alzheimer’s drug after the agency drew sharp criticism for its broad approval of the drug last month without
COVID vaccines and heart inflammation in young adults a ‘likely’ link: CDC panel Fox News medical contributor Dr. Janette Nesheiwat argues the condition is extremely rare and says vaccine benefits outweigh any potential side effects.
FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that
Heart issues on the rise He says this young man’s story shows the important link between the virus and direct heart damage. U.S. health regulators warned surgeons Thursday to stop implanting a heart pump made
FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of
Pfizer and partner BioNTech announced they are starting the process to seek full Food and Drug Administration approval in the U.S. for their COVID-19 vaccine. Since December, their vaccine has been distributed in the U.S.
The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting